History and Mission

Xigen SA is a Swiss biopharmaceutical company formed as a spin-off from the University Hospital of Lausanne (CHUV) and was founded in 2002 in Lausanne, Switzerland. It currently employs 14 highly qualified collaborators.
Xigen mission is to develop innovative and specific therapeutics inhibiting intracellular protein-protein interactions for the treatment of major diseases : inflammatory diseases, CNS diseases, cancers, viral infections.